| [1] |
CZŁONKOWSKA A, LITWIN T, DUSEK P, et al. Wilson disease[J]. Nat Rev Dis Primers, 2018, 4(1): 21. DOI: 10.1038/s41572-018-0018-3. |
| [2] |
YAO BL, ZHANG XX, HAN Y. Progress in gene diagnosis of hepatolenticular degeneration[J]. J Intern Med Concepts Pract, 2021, 16(5): 354-358. DOI: 10.16138/j.1673-6087.2021.05.013. |
| [3] |
Neurogenetics group, Neurology branch, Chinese Medical Association. Chinese guidelines for diagnosis and treatment of hepatolenticular degeneration 2021 [J]. J Chin Neurol, 2021, 54(4): 310-319. DOI: 10.3760/cma.j.cn113694-20200826-00661. |
| [4] |
LEE HW, KANG JD, YEO CW, et al. Hypopituitarism presenting as adrenal insufficiency and hypothyroidism in a patient with wilson's disease: a case report[J]. J Korean Med Sci, 2016, 31(8): 1345-1348. DOI: 10.3346/jkms.2016.31.8.1345. |
| [5] |
DAUTH N, MVCKE VT, MVCKE MM, et al. Hypopituitarism in Wilson's disease resolved after copper-chelating therapy[J]. Endocrinol Diabetes Metab Case Rep, 2021, 2021: 20-0086. DOI: 10.1530/EDM-20-0086. |
| [6] |
ZHANG QJ, XU LQ, WANG C, et al. Four-year follow-up of a Wilson disease pedigree complicated with epilepsy and hypopituitarism: Case report with a literature review[J]. Medicine (Baltimore), 2016, 95(49): e5331. DOI: 10.1097/MD.0000000000005331. |
| [7] |
FERENCI P, OTT P. Wilson's disease: Fatal when overlooked, curable when diagnosed[J]. J Hepatol, 2019, 71(1): 222-224. DOI: 10.1016/j.jhep.2019.02.002. |
| [8] |
European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Wilson's disease[J]. J Hepatol, 2012, 56(3): 671-685. DOI: 10.1016/j.jhep.2011.11.007. |
| [9] |
ZHAO M, LIU R, HU X. A case of Wilson's disease with central diabetes insipidus as the initial manifestation[J]. J Chin Hepatol, 2020, 36(5): 1117-1119. DOI: 10.3969/j.issn.1001-5256.2020.05.034. |
DownLoad: